Previous close | 11.60 |
Open | 11.61 |
Bid | 11.35 x 1200 |
Ask | 11.63 x 1800 |
Day's range | 11.29 - 11.69 |
52-week range | 10.78 - 29.44 |
Volume | |
Avg. volume | 2,794,596 |
Market cap | 4.6B |
Beta (5Y monthly) | 0.95 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.22 |
Earnings date | 28 Feb 2024 - 04 Mar 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 22.53 |
AUSTIN, Texas, November 07, 2023--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the 5th Annual Wolfe Research Healthcare Conference, including a fireside chat presentation on Tuesday, November 14 at 10:15 AM Eastern Time.
agilon health, inc. (NYSE:AGL) Q3 2023 Earnings Call Transcript November 5, 2023 Operator: Hello, everyone. Welcome to the agilon health Third Quarter 2023 Earnings Conference Call. My name is Carla, and I will be your operator for today’s call. Today’s call will include a Q&A session. [Operator Instructions]. I would now hand you over to […]
Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.